x 

0 Activities
0 Activities
    • No Saved Activities

Video

  2. Home
  3. Education
  4. Content Type
  5. Video
  6. Specialty Area
Page 3 of 11
Results 121 - 180 of 619
lyso
Emerging Biomarker Strategies for Lysosomal Storage Diseases
9262 ntm gr enduring
NTM-LD: Improving Diagnosis, Individualized Treatment, and Adherence
animation-263x149
Encouraging Shared Decision-Making with MS Patients
9252 schiz
Cognitive Impairment Associated With Schizophrenia
9194 chILD module
Childhood ILD: Increasing Awareness, Diagnosis, & Patient Management
9235-0005_thumb
Recent Developments in Immune Therapies for Multiple Sclerosis
9444 fabry
A Focus on Fabry Disease: An EXPLORE™ eLearning Module
9256-0001-Thumb
Spring Neuromuscular Conference Updates
9263 NCFBE
The Burden of Bronchiectasis: A Focus on NCFBE Pathophysiology
9235-mod4-263x149
The Connection Between Viruses and Other Factors Contributing to the Development of MS
9193-case3
SSc-ILD With Rapid Progression
9193-case2
Delayed Diagnosis of SSc-ILD with PPF
9235-panel1
Advances in the Understanding of MS Immunology, Therapies, & Biomarkers
9235-panel2
Individualized Care Plans and Emerging Tools for Patient Monitoring
9235-berger-mod
The Role of B Cells in Progressive MS and the Long-term Effects of B Cell Depletion
9199-hepatic2
Treating HCC Cases with Locoregional and Systemic Therapies
9199-hepatic1
Evolving Systemic Treatments for Hepatocellular Carcinoma: Multidisciplinary Strategies
9185-combined
Biomarker-Driven Treatment of Metastatic Colorectal Cancer
9193-case1
Identifying the Signs and Symptoms of PPF
9191-icos
Treating & Assessing Treatment Response: AL Amyloidosis
Option05
The Advancing Treatment Landscape in Amyloidosis: Are You Ready?
9232-module1
Identify the Etiology of Aplastic Anemia in Patients
9232-module2
Recognizing Risk and Benefits of Management Options for Aplastic Anemia
9232-module3
Considerations for Special Populations With Aplastic Anemia
9198-start
Stroke Prevention Through Afib Recognition & Treatment
9234 kca
Immune Checkpoint Inhibitors and RCC: Where Are We Now?
9171-ash-explore
Gene Therapy for Hemophilia: An EXPLORE Learning Experience
9197-hcc1
Evolving Treatment Options for the Treatment of HCC with Immunotherapy and LDT
01.DMD-VirtueMart5
DMD Micro-Learning Library
cttp_thumb_264x150
cTTP: Protecting Patients, Today and Tomorrow
9170-0011_263x149
DMD Conference Coverage: ICNMD and WMS
9156-LSD-264x150
Understanding Lysosomal Storage Disorders: From Newborn Screening to Treatments
9162-0001-DMD_264x150
Gene Therapy and the Future of DMD Treatment: An EXPLORE Learning Experieince
9165 pneumo explore
Utilizing ACIP's Updated Pneumococcal Recommendations
9152-sma-explore
Updates in Spinal Muscular Atrophy: An EXPLORE Learning Experience
9165 product
Utilizing ACIP's Updated Pneumococcal Recommendations - Rapid Recap
Image20220927093935
Growing Importance of Newborn Screening in DMD
Image20220927093938
The Immune Response in DMD Gene Therapies
Image20220927093921
New Data from Gene Therapy Clinical Trials in DMD
Image20220927093941
Changing the Phenotype of DMD
9078_DMD-icon9
DMD and Gene Therapy: What's on the Horizon?
9155-cart-cell
CAR T-Cell Therapy Consults: Navigating a New Landscape
9167-0001-263x149
Treating Persistent/Chronic ITP: Current Care, Future Potential
Am I Treating My Patients With Psoriatic Disease Effectively?
Am I Treating My Patients with Psoriatic Disease Effectively?
No image set
Strategies for Assessing and Managing DOAC-Related Bleeding
No image set
Managing Side Effects of Newer Therapies for Acute Lymphoblastic Leukemia (ALL)
9166-covid
Reducing the Risk of Severe Illness for Patients With COVID-19
No image set
Emerging Treatments in Chronic GvHD
No image set
Treatment of Ph+ Relapsed/Refractory ALL
No image set
Treatment of Ph- Relapsed/Refractory ALL
9157-mod2
Treating Complex Cases of NTM-LD
9157-mod1
NTM-LD Diagnosis and Management
9157-0003-slide263x149
NTM-LD Daignosis and Management - Slide Deck
9143 Thumb
Emerging Nonfactor Approaches for Patients with Hemophilia
No image set
Identification of Relapsed ALL
No image set
ILD Patient Case Library: IPF, PF-ILD, SSc-ILD, and Post COVID-19
9089_nsclc_titleslide
TARGET for NSCLC: Genomic Pathways and Use of EGFR Therapies
No image set
PAH: Risk Reduction Strategies Using Single and Combination Therapies
No image set
Ensuring Effective Care Transitions in Beta Thalassemia
9102-chest-slides
IPF Management and Antifibrotic Therapy - Slide Deck
Page 3 of 11

Search